Evidence map›Paper›PMID 41040691›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Beyond

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa W Jayawardana, Laura Twomey, Céline M Laumont, Catherine J Kennedy, Adelyn Bolithon, Nicola S Meagher and 138 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

148 authors.

Tibor A ZwimpferPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.ORCID 0000-0002-1574-6572
Sian FeredayPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Ahwan PandeyPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Dinuka AriyaratnePeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Madawa W JayawardanaPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Laura TwomeyPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Céline M LaumontDeeley Research Centre, BC Cancer. Victoria, BC, Canada.
Catherine J KennedyCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia, 2145.
Adelyn BolithonSchool of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia, 2052.
Nicola S MeagherSchool of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia, 2052.
Katy MilneDeeley Research Centre, BC Cancer. Victoria, BC, Canada.
Phineas HamiltonDeeley Research Centre, BC Cancer. Victoria, BC, Canada.
Jennifer AlsopDepartment of Oncology, University of Cambridge. Cambridge, UK, CB2 0QQ.
Antonis C AntoniouCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, CB1 8RN.
George Au-YeungPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Matthias W BeckmannDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg. University Hospital Erlangen, Erlangen, Germany, 91054.
Amy Berrington de GonzalezDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.
Christiani BisinottoDepartment of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo. Ribeirão Preto, Brazil.
Freya BlomeInstitute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany.
Clara BodelonDepartment of Population Science, American Cancer Society, Atlanta, GA, USA, 30303.
Jessica BorosCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia, 2145.
Alison H BrandDepartment of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia, 2145.
Michael E CarneyDepartment of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Alicia Cazorla-JiménezPathology Department, Fundación Jiménez Díaz. Madrid, Spain.
Derek S ChiuBritish Columbia's Gynecological Cancer Research Team OVCARE, University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada, V5Z 4E6.
Elizabeth L ChristiePeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Anita Chudecka-GłazDepartment of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland, 70-111.
Penny CoulsonDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.
Kara L Cushing-HaugenProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA, 98109.
Cezary CybulskiDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS, USA, 39762.
Kathleen M DarcyGynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Cath DavidGynaecological Cancer Centre, Royal Hospital for Women, Randwick, New South Wales, Australia.
Trent DavidsonNSW Health Pathology, Prince of Wales Hospital. Sydney, New South Wales, Australia.
Arif B EkiciInstitute of Human Genetics. Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg FAU, Erlangen, Germany, 91054.
Esther ElishaevDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Julius EmonsDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg. University Hospital Erlangen, Erlangen, Germany, 91054.
Tobias EnglerDepartment of Women's Health, Tuebingen University Hospital, Tuebingen, Germany, 72076.
Rhonda FarrellFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia, 2006.
Anna FischerInstitute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany.
Montserrat García-ClosasDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.ORCID 0000-0003-1033-2650
Aleksandra Gentry-MaharajMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK, WC1V 6LJ.
Prafull GhatageDepartment of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary. Calgary, AB, Canada.
Rosalind GlasspoolBeatson West of Scotland Cancer Centre and School of Cancer Sciences, University of Glasgow, Glasgow, UK, G12 0YN.
Philipp HarterDepartment of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany, 45136.
Andreas D HartkopfDepartment of Women's Health, Tuebingen University Hospital, Tuebingen, Germany, 72076.
Arndt HartmannInstitute of Pathology, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany, 91054.
Sebastian HeikausCenter for Pathology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
Brenda Y HernandezUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Anusha HettiaratchiThe Health Precincts Biobank, UNSW Biospecimen Services, Mark Wainwright Analytical Centre, UNSW, Sydney, New South Wales, Australia.
Sabine HeubleinDepartment of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany.
David G HuntsmanDepartment of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada, V5Z 1L3.
Mercedes Jimenez-LinanDepartment of Histopathology, Addenbrooke's Hospital, Cambridge, UK.
Michael E JonesDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.ORCID 0000-0001-7479-3451
Eunyoung KangDepartment of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea, 13260.
Ewa KaznowskaDepartment of Pathology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.
Tomasz KluzDepartment of Gynecology, Gynecology Oncology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland.
Felix K F KommossInstitute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Gottfried KonecnyDavid Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA, 90095.
Roy F P M KruitwagenDepartment of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Jessica KwonDepartment of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada, V5Z 1L3.
Diether LambrechtsLaboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium, 3000.
Cheng-Han LeeDepartment of Pathology and Laboratory Medicine, University of Alberta, Edmonton, Alberta, Canada.
Jenny LesterDavid Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA, 90095.
Samuel C Y LeungBritish Columbia's Gynecological Cancer Research Team OVCARE, University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada, V5Z 4E6.
Yee LeungDepartment of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
Anna LinderDepartment of Obstetrics and Gynecology, Institute of Clinical Science, Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.
Jolanta LissowskaDepartment of Cancer Epidemiology and Prevention, M Sklodowska-Curie National Research Oncology Institute, Warsaw, Poland, 02-034.
Liselore LoverixDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics. Leuven Cancer Institute. Leuven, Belgium, 3000.
Jan LubińskiDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, 71-252.
Constantina MateoiuDepartment of Pathology, University of Gothenburg, Gothenburg, Sweden.
Iain A McNeishDivision of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK, W12 0NN.ORCID 0000-0002-9387-7586
Malak MoubarakDepartment of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany, 45136.
Gregg S NelsonDepartment of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary. Calgary, AB, Canada.
Nikilyn NevinsCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia, 2145.
Alexander B OlawaiyeDivision of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, 15213.
Siel OlbrechtDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics. Leuven Cancer Institute. Leuven, Belgium, 3000.
Sandra OrsulicDavid Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA, 90095.
Ana OsorioGenetics Service, Fundación Jiménez Díaz University Hospital and Health Research Institute, Universidad Autónoma de Madrid IIS-FJD, UAM, Madrid, Spain, 28040.
Carmel M QuinnThe Health Precincts Biobank, UNSW Biospecimen Services, Mark Wainwright Analytical Centre, UNSW, Sydney, New South Wales, Australia.
Ganendra Raj MohanDepartment of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
Isabelle Ray-CoquardCentre Leon Berard and University Claude Bernard Lyon 1, Lyon, France, 69373.
Cristina Rodríguez-AntonaCentre for Biomedical Network Research on Rare Diseases CIBERER, Instituto de Salud Carlos III, Madrid, Spain, 28029.
Patricia RoxburghSchool of Cancer Sciences, University of Glasgow, Glasgow, UK, G61 1QH.
Matthias RuebnerDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg. University Hospital Erlangen, Erlangen, Germany, 91054.
Stuart G SalfingerDepartment of Gynaecological Oncology, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.
Spinder SamraCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia, 2145.
Minouk J SchoemakerDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.
Hans-Peter SinnInstitute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Gabe S SonkeDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands, 1066 CX.
Linda SteeleDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA, 91010.
Colin J R StewartDivision of Obstetrics and Gynaecology, Medical School, University of Western Australia, Crawley, Western Australia, Australia.
Aline TalhoukBritish Columbia's Gynecological Cancer Research Team OVCARE, University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada, V5Z 4E6.
Adeline TanDivision of Obstetrics and Gynaecology, Medical School, University of Western Australia, Crawley, Western Australia, Australia.
Christopher M TarneyGynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Sarah E TaylorDivision of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, 15213.
Koen K Van de VijverDepartment of Pathology, Ghent University Hospital, Cancer Research Institute Ghent CRIG, Ghent, Belgium.
Maaike A van der AaDepartment of Research, Netherlands Comprehensive Cancer Organization IKNL, Utrecht, the Netherlands.
Toon Van GorpDivision of Gynaecological Oncology, Leuven Cancer Institute, University Hospital Leuven and KU Leuven, Leuven, Belgium.
Els Van NieuwenhuysenDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics. Leuven Cancer Institute. Leuven, Belgium, 3000.
Lilian van-WagensveldDepartment of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Andrea E Wahner-HendricksonDepartment of Oncology, Mayo Clinic, Rochester, MN, USA, 55905.
Christina WalterDepartment of Women's Health, Tuebingen University Hospital, Tuebingen, Germany, 72076.
Chen WangDepartment of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA, 55905.ORCID 0000-0003-2638-3081
Julia WelzDepartment of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany, 45136.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA, 20892.
Lynne R WilkensUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Stacey J WinhamDepartment of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA, 55905.
Boris WinterhoffDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA, 55455.
Michael S AnglesioBritish Columbia's Gynecological Cancer Research Team OVCARE, University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada, V5Z 4E6.ORCID 0000-0003-1639-5003
Andrew BerchuckDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA, 27710.
Francisco J Candido Dos ReisDepartment of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo. Ribeirão Preto, Brazil.
Paul A CohenDepartment of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
Thomas P ConradsGynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.ORCID 0000-0003-4742-3281
Philip CroweSchool of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia, 2052.
Jennifer A DohertyHuntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA, 84112.
Peter A FaschingDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg. University Hospital Erlangen, Erlangen, Germany, 91054.
Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Center DKFZ, Heidelberg, Germany, 69120.
María J GarcíaGenomic Biomarkers and Precision Oncology Group, Sols-Morreale Biomedical Research Institute IIBM, Consejo Superior de Investigaciones Cientficas & Universidad Autónoma de Madrid CSIC-UAM, Madrid, Spain, 28029.
Simon A GaytherMedicine, University of Texas Health, San Antonio, San Antonio, USA, 78229.
Marc T GoodmanCancer Prevention and Control Program, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA, 90048.
Jacek GronwaldDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, 71-252.
Holly R HarrisProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA, 98109.
Florian HeitzDepartment of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany, 45136.
Hugo M HorlingsDepartment of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands, 1066 CX.
Beth Y KarlanDavid Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA, 90095.
Linda E KelemenCommunicable Disease Epidemiology Section, South Carolina Department of Public Health, Columbia, SC, USA.
G Larry MaxwellGynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Usha MenonMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK, WC1V 6LJ.
Francesmary ModugnoDivision of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, 15213.
Susan L NeuhausenDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA, 91010.
Joellen M SchildkrautDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA, 30322.
Annette StaeblerInstitute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany.
Karin SundfeldtDepartment of Obstetrics and Gynecology, Institute of Clinical Science, Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.
Anthony J SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.
Ignace VergoteDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics. Leuven Cancer Institute. Leuven, Belgium, 3000.
Anna H WuDepartment of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 90033.
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK, CB2 0RE.ORCID 0000-0002-5738-6683
Paul D P PharoahDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA, USA, 90069.ORCID 0000-0001-8494-732X
Celeste Leigh PearceDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA, 48109.
Malcolm C PikeDepartment of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 90033.
Ellen L GoodeDepartment of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA, 55905.
Susan J RamusSchool of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia, 2052.
Martin KöbelDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada, T2N 2T9.ORCID 0000-0002-6615-2037
Brad H NelsonDeeley Research Centre, BC Cancer. Victoria, BC, Canada.
Anna DeFazioCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia, 2145.
Michael L FriedlanderGynaecological Cancer Centre, Royal Hospital for Women, Randwick, New South Wales, Australia.
David D L BowtellPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.
Dale W GarsedPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia, 3000.ORCID 0000-0003-1223-0121

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Pallav Pokhrel · 1996 to 2026
$56.2M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI SCOTT H KAUFMANN · 2009 to 2026
$37.0M
WITHIN SUBJ VARIABILITY IN MEASUREMENTS DRUG METABOL ENZYMES IN HLTY SUBJM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVINE, ARTHUR S · 1985 to 2006
$29.2M
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and RiskR01CA248288 · NCI · MAYO CLINIC ROCHESTER · PI Stacey J Winham · 2021 to 2026
$4.8M
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian CancerR01CA172404 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RAMUS, SUSAN J · 2013 to 2017
$2.9M
Inflammation and Ovarian CancerR01CA095023 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUNKER, CLAREANN H. · 2003 to 2008
$2.7M
Epidemiologic factors and survival by molecular subtypes of ovarian cancerR01CA168758 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DOHERTY, JENNIFER A., ROSSING, MARY ANNE · 2013 to 2016
$2.6M
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERSK07CA080668 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MODUGNO, FRANCESMARY · 2000 to 2005
$661k
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and OutcomesR21CA267050 · NCI · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MODUGNO, FRANCESMARY · 2022 to 2023
$408k
NCI NIH HHS K07 CA080668NCI NIH HHS P30 CA015083NCI NIH HHS P30 CA071789NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA095023NCI NIH HHS R01 CA168758NCI NIH HHS R01 CA172404NCI NIH HHS R01 CA248288NCI NIH HHS R21 CA267050NCRR NIH HHS M01 RR000056
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41040691
PMCPMC12486008

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.